Service Areas/Connecticut

M&A Advisory in Connecticut

Connecticut hosts 70+ private equity firms in Fairfield County alone, driving Very High M&A activity with insurance, aerospace, and financial services businesses trading at 10-16x EBITDA.

Market Overview

Connecticut's M&A Economy

Connecticut punches dramatically above its size in M&A activity, driven by Fairfield County's role as the "Hedge Fund Capital of the World" with 200+ managers. The state's 6.99% top personal rate compares favorably to NY's ~10.9% plus NYC's 3.876%, creating a ~7-point arbitrage that has driven 161,456 net migrants from NY since 2013. Deal volume in 2025 tracked a Q3-Q4 recovery with platform deals up 42-43% YoY and sponsor average EV/EBITDA at ~12.0x. Structural advantages include proximity to NYC capital markets (45-minute Metro-North), the nation's highest concentration of insurance HQs, and Defense Manufacturing Community status anchoring 21% of all US aircraft engine GDP.

Connecticut at a Glance

State GDP
$340-345B
Total Businesses
368K+
LMM Businesses
13,000-15,000
Key Metro
Stamford-Hartford-New Haven
Major Markets

Key Markets in Connecticut

Stamford / Greenwich (Fairfield County)

Financial Services/PEInsuranceMedia/Advertising

The epicenter of CT M&A and dominant LMM deal hub. Hosts Stone Point, Clearview, L Catterton, NewCastle, KarpReilly, and the nation's densest hedge fund cluster. Continued inbound migration from Manhattan-based PE professionals is expanding the dealmaker base.

Hartford

InsuranceAerospace & DefenseHealthcare

"The Insurance Capital of the World," anchoring CT's #1 M&A vertical with Travelers, The Hartford, CVS/Aetna, Cigna. Also a growing aerospace M&A hub via Pratt & Whitney's East Hartford HQ and its supplier network.

New Haven

Bioscience/PharmaMedical DevicesEducation Services

Yale-anchored bioscience and healthcare M&A corridor. CT ranks 5th nationally for patent creation and private R&D per capita. Expanding with 2025 investments by MannKind, Cyclo Therapeutics, and P2 Science.

Waterbury / Groton-New London

Advanced ManufacturingDefense/MarinePharmaceuticals

Legacy advanced manufacturing cluster with active strategic and PE roll-up activity. Groton anchors Electric Boat submarine production and Pfizer R&D. Naugatuck Valley retains precision metals, tooling, and specialty fabrication.

Market Comparison

How Does Connecticut Compare?

Connecticut M&A benchmarks vs. neighboring states.

Metric
CTConnecticut
MA
NY
RI
State GDP
$340-345B
$815B
$2.47T
$75-78B
LMM Businesses
13,000-15,000
18,000-22,000
43,000-50,000
2,700-3,200
Avg. Deal Size
$25M
$18-28M
$15-22M
$15M
PE Activity
Very High
Very High
Very High
Moderate
Top Industry
Insurance/Financial
Life Sciences
Finance/Tech
Healthcare/Defense
Corp. Tax Rate
7.5% + 10% surtax
8.0%
6.5-7.25%
7.0%
Deal Volume Rank
Top 15-20
Top 5-7
#1-2
~45th
Deal Landscape

Connecticut Deal Landscape 2025-2026

CT deal activity in 2025 was bifurcated: large-cap take-privates ran hot (Apollo/Barnes $3.6B, Stanley Black & Decker/CAM $1.8B, Travelers Canada $2.4B), while LMM deal count tracked the national pattern of H1 decline before H2 recovery. The dominant buyer type is private equity, led by the Greenwich/Stamford/Westport sponsor cluster. The biggest driver is founder-generational ownership transitions combined with $1T+ of PE dry powder.

01

PE Take-Privates of CT Industrial Champions

Apollo closed $3.6B Barnes Group, Arcline completed $1.8B Kaman at ~16x EBITDA, and Stanley Black & Decker is divesting CAM to Howmet for $1.8B. PE is paying mid-teens multiples for proprietary, aftermarket-heavy CT platforms.

02

Greenwich-Led Insurance Mega-Recaps

Stone Point closed Trident X at $11.5B, then led the $7B+ OneDigital recap with CPP Investments. Fairfield County is ground zero for broker consolidation even as overall deal count fell to a four-year low.

03

Strategic Portfolio Pruning

Travelers sold Canadian P&C for $2.4B at 1.8x book. Cigna completed $3.7B Medicare sale. RTX sold Simmonds Precision to TransDigm for $765M. CT anchors are aggressively reshaping portfolios.

04

CT-Native Sponsor LMM Roll-ups

Gemspring, Heartwood ($1.4B AUM), Altus, Hamilton Robinson, Charter Oak, Clearview, and Gainline ($400M Fund II) drive tuck-in volume across specialty manufacturing, business services, and healthcare.

Your Exit Roadmap

Exit Preparation Timeline

A practical roadmap for Connecticut business owners planning an exit.

1
24 Months Out
Foundation
  • Model CT PET election impact versus direct owner taxation for transaction-year income
  • Run CT-specific QSBS qualification review — confirm C-corp status, gross assets under $75M (post-OBBBA), active-business test
  • Inventory all CT real property to quantify CITT exposure under CGS §12-638b
  • Begin residency/domicile analysis and coordinate pre-sale CT estate/gift planning given non-portable $15M exemption
2
12 Months Out
Preparation
  • Complete quality of earnings with CT-specific add-backs (PET expense, CBT 10% surcharge, R&D credits)
  • If insurance target, begin pre-filing with CT Insurance Department on Form A / §38a-130 process
  • Perform sales/use tax nexus review and remediate via DRS voluntary disclosure
  • Structure analysis: asset vs. stock vs. F-reorg vs. 338(h)(10) modeling CITT and conveyance tax interplay
3
6 Months Out
Execution
  • Finalize deal structure; if asset sale, prepare buyer's Form AU-866 Request for Tax Clearance (60-day DRS window)
  • File CT Insurance Department Form A for domestic insurer targets (public hearing within 30 days)
  • Calculate preliminary Form AU-330 CITT liability; obtain current appraisals for real property FMV
  • Confirm CT PET 2024/2025 estimated payments are current to preserve election
4
Closing
60-90 Days
  • Obtain DRS tax clearance certificate or fund the escrow amount specified in DRS escrow letter
  • File Form AU-330 and pay CITT, plus Form OP-236 real estate conveyance tax
  • Execute CT Insurance Commissioner's Order approving Form A acquisition
  • Coordinate final Form CT-PET filing and individual CT-1040 to claim the 87.5% PET credit
Why Us

Why Connecticut Business Owners Choose Ad Astra

Local market knowledge and national buyer networks — the combination that drives premium outcomes for Connecticut business owners.

Schedule a Consultation
01

Hartford Insurance Capital Expertise

We navigate CT Insurance Department Form A approvals under CGS §38a-130, Form E competitive filings, and public hearings. We sequence Form A with DRS tax clearance and CITT filings so regulatory and tax approvals close simultaneously.

02

Defense & Aerospace Access

We advise on ITAR/EAR-controlled technology, DoD CAGE code transfer, CFIUS review, and DCAA-compliant cost accounting for CT's Pratt & Whitney, Electric Boat, and Sikorsky supply chains.

03

CT Tax Regime Optimization

We model every deal against CT's 6.99% top rate, elective PET with 87.5% credit, QSBS conformity, 1.11% CITT, tiered conveyance tax, and non-portable 12% estate tax. We typically save sellers 4-8% of enterprise value.

04

Fairfield County PE Network

Our relationships span 70+ PE firms in Greenwich/Stamford/Westport, Hartford's financial corridor, and New Haven's biotech ecosystem. This gives sellers direct access to the most capital-dense corridor in the country.

Market Pulse

Connecticut M&A Activity Highlights

Live Market Intelligence

Apollo closed its $3.6B take-private of Bristol-based Barnes Group at $47.50/share, a 20% premium to June 2024 trading

Stanley Black & Decker signed $1.8B agreement to sell Consolidated Aerospace Manufacturing to Howmet, with H1 2026 close expected

TransDigm acquired Simmonds Precision Products from RTX for $765M, with ~$350M expected revenue and ~40% aftermarket mix

Stone Point Capital and CPP Investments closed >$7B majority recap of OneDigital in December 2025

Archway Dental Partners became CT's largest DSO with a five-practice CT Dental Management acquisition in September 2025

Tax & Structure

Connecticut Tax & Deal Structure

Connecticut sits among the higher-tax Northeastern states for M&A sellers: personal income taxed up to 6.99% with no preferential capital gains rate, a standalone estate and gift tax, and the only state imposing a controlling interest transfer tax on indirect real estate transfers.

State Income Tax / PET

Neutral

CT imposes progressive rates from 2% to 6.99% on income above $500K/$1M. The Pass-Through Entity Tax became elective in 2024, providing a SALT-cap workaround at 6.99% with an 87.5% member credit. Well-timed PET elections preserve federal SALT-cap benefit on transaction-year income.

Capital Gains Treatment

Unfavorable

Connecticut taxes capital gains as ordinary income at the same 2-6.99% rates. Combined with federal 20% LTCG plus 3.8% NIIT, CT-resident founders face an all-in rate of roughly 30.8% on non-QSBS gain — among the highest in the Northeast.

QSBS Section 1202 Conformity

Favorable

CT conforms to federal QSBS exclusion because the income tax starts from federal AGI. Post-OBBBA, tiered 50/75/100% exclusion at 3/4/5 years with $15M per-issuer cap and $75M gross-asset ceiling. For CT tech and defense founders, the single most powerful planning tool.

Asset vs. Stock Sale

Unfavorable

CT imposes 6.35% sales and use tax on tangible personal property in asset sales. Buyers must submit Form AU-866 for Tax Clearance Certificate (60-day DRS window). Real estate conveyance tax adds 0.75-2.25% on property transfers. Stock sales avoid most friction.

Estate & Succession Tax

Neutral

CT has a $13.99M (2025) / $15M (2026) exemption matching federal, with a flat 12% rate and $15M total liability cap. CT is the only state with a standalone gift tax. No spousal portability means pre-exit SLATs, GRATs, and non-grantor trusts are critical above $15M net worth.

Controlling Interest Transfer Tax (CITT)

Unfavorable

Under CGS §12-638b, CT imposes a 1.11% tax on sale of >50% controlling interest in entities owning CT real property. Tax is on full FMV unreduced by mortgages. For a $50M Hartford office building, the stealth tax alone is $555,000. Not credited against regular conveyance tax.

Illustrative Case Study

Representative Transaction: Hartford Specialty Insurance Platform

Illustrative model only. Not representative of a current or past Ad Astra Equity client engagement. Anonymized composite based on comparable CT-market transactions. Figures as ranges.

The Business

Hartford-headquartered specialty P&C platform combining a licensed CT-domiciled carrier and an affiliated MGA, with operations in Stamford and Bridgeport serving middle-market commercial insureds across New England. Founded by a multi-generational CT insurance family with roughly 180 employees.

Key Metrics

Gross Written Premium

$180M-$240M

EBITDA

$28M-$38M

Combined Ratio

88-92%

Renewal Retention

88-93%

The Challenge

Dual key-person risk: the founder-CEO personally underwrote ~40% of top accounts and the Chief Actuary was viewed as indispensable. The transaction required CT Insurance Department Form A approval under CGS §38a-130, including pre-acquisition Form E analysis, biographical affidavits, and a public hearing.

The Process

  • 1Separated the MGA (non-regulated, higher-multiple) from the carrier (regulated) to enable dual-track interest and optimize CITT analysis on Hartford HQ
  • 2Approached 14 strategic buyers plus three family offices; secured five IOIs from national carriers, Bermuda specialty groups, and PE-backed platforms with existing CT Form A approvals
  • 3Negotiated 3-year retention for founder and Chief Actuary with rollover equity; structured pre-closing PET election and QSBS gifting to non-grantor trusts
  • 4Coordinated Form A filing and public hearing, secured DRS Form AU-866 clearance on MGA assets, filed CITT on indirect Hartford real estate transfer

Deal Outcome

Enterprise Value

9.5-11.5x EBITDA

Premium vs. Market

18-26%

Time to Close

9-11 months

Seller Rollover

10-15% rollover equity

Key Lessons

  • CT Form A timing drives the deal clock — pre-file informal drafts and line up biographical affidavits before signing LOI to avoid 60-120 day surprises
  • CITT is a stealth cost in every CT deal touching real estate — even on pure stock sales, the 1.11% tax on FMV can reach seven figures; model it early
  • Pair CT PET elections with federal QSBS planning — PET captures SALT-cap benefit on transaction-year ordinary income while §1202 shelters up to $15M of C-corp gain
FAQ

Frequently Asked Questions

Common questions about selling a business in Connecticut.

Still have questions? Let's talk

Also serving neighboring states

Start the Conversation

Ready to Explore Your Connecticut Exit?

Schedule a confidential conversation to discuss your Connecticut business, your goals, and how our local expertise and national buyer network can maximize your outcome.

100% Confidential
Connecticut Expertise
No Obligation